A US court has ruled that a sperm bank can be sued for selling sperm
that causes a child to have a genetic defect. The case was brought on
behalf of a 13-year-old girl with Fragile-X syndrome, a common cause of
mental retardation and shines more light on the market for
sperm. According to the judgement, in 1994, Donna Donovan found a
company which promised first-class sperm. Idant Laboratories guaranteed
that its semen was exceptionally safe, that its screening standards
were excellent, and that its donors had been rigorously screened for a good
genetic background. Unfortunately donor G738 was a carrier for Fragile
X. The child's problems became apparent in 1998, but two doctors
engaged by Idant still insisted that they were not related to Fragile-X
syndrome nor to the donated sperm. Ms Donovan accepted this and it was
not until a case report about her daughter was published in a medical
journal that she realised that the sperm donor had definitely been a
carrier. The case is still in its early stages, but no doubt will be
watched anxiously by all sperm merchants. ~Wall Street Journal, Apr 9
Consequences of the Bio-Medical Revolution
May 1, 2010, Biola University, La Mirada, CA
Helping nurses understand technological advances in health care and their ethical consequences.
Fertility, Infertility and Gender
June 16-18, 2010, Maynooth, Ireland (near Dublin)
Sponsored by the Linacre Centre for Healthcare Ethics, Oxford.
Obama’s Illegal Stem-Cell Policy
Public Discourse
Obama’s stem-cell policy is not only contrary to sound reason and good science, it violates the law.
The hidden story of Britain’s ‘snowbabies’
London Telegraph
There are tens of thousands of 'spare' IVF embryos currently in storage in Britain, but parents face an agonising choice…
Letting Go
New Yorker
What should medicine do when it can’t save your life? asks Atul Gawande